Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4231 to 4245 of 8908 results

  1. Syndication service application

    Home Reusing our content...

  2. Use of NICE content in the UK

    Home Reusing our content...

  3. Use of our content internationally

    Using our content internationally. Includes information on fees and licensing agreements for both AI and non AI requests.

  4. Use of our content for AI purposes

    Using NICE content for AI purposes. Includes complete content, adaptation, contextualisation, translation, selected extracts and the use of our COVID-19 content internationally.

  5. What content is available for reuse?

    Learn more about what NICE content is available for reuse by checking our information asset register.

  6. Is there any content I cannot reuse?

    Learn about situations where you cannot use NICE content.

  7. Reusing our content

    Find out how and where you can reuse NICE's content. Includes use of our content in the UK, use of our content internationally, use of our content for AI purposes, our content assurance process, and our information asset register.

  8. Indicator advisory committee members

    Read biographies for all members of NICE's indicator advisory committee.

  9. Executive team meetings

    Home About us Executive team...

  10. Accessibility

    NICE wants as many people as possible to be able to use our services, and we have designed it to be accessible.

  11. A new model for evaluating and purchasing antimicrobials in the UK

    Overview of NICE and NHS England’s pioneering subscription-style purchasing model for antimicrobials: its pilot with ceftazidime-avibactam and cefiderocol in 2022, expansion in 2024, supporting health technology assessments, downloadable guidance and procurement tools.

  12. Guidance, NICE advice and quality standards in development

    View a complete list of all our guidance, NICE advice and quality standards currently in development

  13. Content assurance service

    Our content assurance service. Includes what the service offers, how to apply and pricing.

  14. Hypertension: ECG for target organ damage (IND123)

    This indicator covers the percentage of patients with a new diagnosis of hypertension in the preceding 1 April to 31 March who have a record of a 12-lead ECG performed in the 3 months before or after the date of entry to the hypertension register. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM77

    General practice indicators suitable for use in QOF
    Last updated
    4 November 2020

  15. Epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer (HTG714)

    Evidence-based recommendations on epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer. This involves radioactive paste being spread on foil over the top of the cancer, to destroy the cancer cells.

    HealthTech guidance
    Published
    2 April 2024
    View recommendations

    Sections for HTG714